Literature DB >> 30478910

Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes.

Markus Leitinger1,2, Eugen Trinka1,2,3, Giada Giovannini4, Georg Zimmermann1,2,5, Cristina Florea1,2, Alexandra Rohracher1,2, Gudrun Kalss1,2, Caroline Neuray1,2, Rudolf Kreidenhuber1,2, Julia Höfler1,2, Giorgi Kuchukhidze1,2, Claudia Granbichler1, Judith Dobesberger1,2, Helmut F Novak1,2, Georg Pilz1,2, Stefano Meletti4,6, Uwe Siebert3,7,8.   

Abstract

OBJECTIVE: In 2015, the International League Against Epilepsy (ILAE) proposed a new definition of status epilepticus (SE): 5 minutes of ongoing seizure activity to diagnose convulsive SE (CSE, ie, bilateral tonic-clonic SE) and 10 minutes for focal SE and absence SE, rather than the earlier criterion of 30 minutes. Based on semiology, several types of SE with prominent motor phenomena at any time (including CSE) were distinguished from those without (ie, nonconvulsive SE, NCSE). We present the first population-based incidence study applying the new 2015 ILAE definition and classification of SE and report the impact of the evolution of semiology and level of consciousness (LOC) on outcome.
METHODS: We conducted a retrospective population-based incidence study of all adult patients with SE residing in the city of Salzburg between January 2011 and December 2015. Patients with hypoxic encephalopathy were excluded. SE was defined and classified according to the ILAE 2015.
RESULTS: We identified 221 patients with a median age of 69 years (range 20-99 years). The age- and sex-adjusted incidence of a first episode of SE, NCSE, and SE with prominent motor phenomena (including CSE) was 36.1 (95% confidence interval [CI] 26.2-48.5), 12.1 (95% CI 6.8-20.0), and 24.0 (95% CI 16.0-34.5; including CSE 15.8 [95% CI 9.4-24.8]) per 100 000 adults per year, respectively. None of the patients whose SE ended with or consisted of only bilateral tonic-clonic activity died. In all other clinical presentations, case fatality was lower in awake patients (8.2%) compared with patients with impaired consciousness (33%). SIGNIFICANCE: This first population-based study using the ILAE 2015 definition and classification of SE found an increase of incidence of 10% compared to previous definitions. We also provide epidemiologic evidence that different patterns of status evolution and LOCs have strong prognostic implications.
© 2018 The Authors. Epilepsia published by Wiley Periodicals, Inc. on behalf of International League Against Epilepsy.

Entities:  

Keywords:  classification; epidemiology; evolution; incidence; semiology; status epilepticus

Mesh:

Year:  2018        PMID: 30478910     DOI: 10.1111/epi.14607

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  24 in total

Review 1.  Intravenous Brivaracetam in the Treatment of Status Epilepticus: A Systematic Review.

Authors:  Francesco Brigo; Simona Lattanzi; Raffaele Nardone; Eugen Trinka
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

2.  Epidemiology, management and outcome of status epilepticus in adults: single-center Italian survey.

Authors:  Carlotta Mutti; Angelo Sansonetti; Giampiero Monti; Claudia Vener; Irene Florindo; Anna Elisabetta Vaudano; Irene Trippi; Giorgia Bernabè; Liborio Parrino; Lucia Zinno
Journal:  Neurol Sci       Date:  2021-09-06       Impact factor: 3.307

3.  Utility of the END-IT Score to Predict the outcome of Childhood Status Epilepticus: A Retrospective Cohort Study.

Authors:  Dipti Kapoor; Divyani Garg; Rajiv K Malhotra; Virendra Kumar; Suvasini Sharma
Journal:  Ann Indian Acad Neurol       Date:  2021-06-29       Impact factor: 1.383

4.  Clinico-biological markers for the prognosis of status epilepticus in adults.

Authors:  Aurélie Hanin; Sophie Demeret; Virginie Lambrecq; Benjamin Rohaut; Clémence Marois; Meriem Bouguerra; Alexandre Demoule; Jean-Louis Beaudeux; Randa Bittar; Jérôme Alexandre Denis; Françoise Imbert-Bismut; Foudil Lamari; Benoit Rucheton; Dominique Bonnefont-Rousselot; Mario Chavez; Vincent Navarro
Journal:  J Neurol       Date:  2022-06-29       Impact factor: 6.682

5.  Retrospective External Validation of the Status Epilepticus Severity Score (STESS) to Predict In-hospital Mortality in Adults with Nonhypoxic Status Epilepticus: A Machine Learning Analysis.

Authors:  Francesco Brigo; Gianni Turcato; Giada Giovannini; Stefano Meletti; Simona Lattanzi; Niccolò Orlandi; Giulia Turchi; Arian Zaboli
Journal:  Neurocrit Care       Date:  2022-10-13       Impact factor: 3.532

Review 6.  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies.

Authors:  Catherine A Christian; Doodipala Samba Reddy; Jamie Maguire; Patrick A Forcelli
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

7.  [Epilepsy in the aged : Challenges in diagnostics and treatment].

Authors:  Alexandra Rohracher; Eugen Trinka
Journal:  Z Gerontol Geriatr       Date:  2021-04-23       Impact factor: 1.281

8.  The glucocorticoid receptor specific modulator CORT108297 reduces brain pathology following status epilepticus.

Authors:  Aynara C Wulsin; Kimberly L Kraus; Kevin D Gaitonde; Venkat Suru; Salwa R Arafa; Benjamin A Packard; James P Herman; Steve C Danzer
Journal:  Exp Neurol       Date:  2021-03-18       Impact factor: 5.620

Review 9.  Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies.

Authors:  Simona Lattanzi; Markus Leitinger; Chiara Rocchi; Sergio Salvemini; Sara Matricardi; Francesco Brigo; Stefano Meletti; Eugen Trinka
Journal:  Eur J Neurol       Date:  2021-11-02       Impact factor: 6.288

10.  Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus.

Authors:  Giada Giovannini; Roberta Bedin; Diana Ferraro; Anna Elisabetta Vaudano; Jessica Mandrioli; Stefano Meletti
Journal:  Epilepsia       Date:  2021-11-21       Impact factor: 6.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.